Skip to content

Exhaled Nitric Oxide in healthy children 1 - 4 years old

Exhaled Nitric Oxide in healthy children 1 - 4 years old - Exhaled Nitric Oxide in healthy children 1 - 4 years old

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32593
Enrollment
50
Registered
2010-02-16
Start date
2011-01-24
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma astma

Interventions

None listed

Sponsors

Canisius Wilhelmina Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Healthy children aged 12 - 48 months (1 - 4 years old)

Exclusion criteria

Exclusion criteria: - Medical history of: asthma, viral wheeze, eczema, allergic rhinitis or other allergies/pulmonary diseases - An active upper or lower respiratory tract infection during the eNO-measurement - Medication: β2-sympathicomimetics, inhalation corticosteroids, leukotriene receptor antagonists or antihistamines

Design outcomes

Primary

MeasureTime frame
exhaled NO (in parts per billion) The mean eNO concentration, the standard deviation and the 95% reference interval (RI) for the eNO will be calculated. The 95% reference interval will be considered as reference values.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)